| 产品描述: | Pyrithioxin dihydrochloride is a neurodynamic compound, combined with a short period of hyperventilation (HV) was applied in cerebral infarct patients with Hemiplegia. |
| 靶点: |
Human Endogenous Metabolite |
| 体内研究: |
Pyrithioxin dihydrochloride (20 mg/kg,灌胃,每周五次) 可延长 3-MC 诱导的皮下纤维肉瘤 WISTAR 大鼠的存活时间,并诱导肿瘤缓解。 Pyrithioxin dihydrochloride (200 and 600 mg/kg diet,口服,6 周) 可提高大鼠的乙酰胆碱水平并改善其记忆行为。 Pyrithioxin dihydrochloride (50-200 mg/kg,口服) 可减少糖尿病大鼠的退缩行为。 |
| 参考文献: |
1. Stoica E, et al. Facilitation through hyperventilation of therapeutic effect of pyrithioxin in cerebral infarct patients. Eur Neurol. 1975;13(4):285-303. |
| 溶解性: |
DMSO : 66.67 mg/mL (151.05 mM; Need ultrasonic) H2O : 50 mg/mL (113.28 mM; Need ultrasonic) |
| 保存条件: |
2-8℃ |
| 配置溶液浓度参考: |
|
1mg |
5mg |
10mg |
| 1 mM |
2.266 ml |
11.328 ml |
22.656 ml |
| 5 mM |
0.453 ml |
2.266 ml |
4.531 ml |
| 10 mM |
0.227 ml |
1.133 ml |
2.266 ml |
| 50 mM |
0.045 ml |
0.227 ml |
0.453 ml |
|
| 注意: |
部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。 |